0001209191-18-018983.txt : 20180312 0001209191-18-018983.hdr.sgml : 20180312 20180312193943 ACCESSION NUMBER: 0001209191-18-018983 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180308 FILED AS OF DATE: 20180312 DATE AS OF CHANGE: 20180312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cochrane Michael CENTRAL INDEX KEY: 0001606872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28000 FILM NUMBER: 18684927 MAIL ADDRESS: STREET 1: 600 GALLERIA PARKWAY STREET 2: SUITE 100 CITY: ATLANTA STATE: GA ZIP: 30342 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRGX GLOBAL, INC. CENTRAL INDEX KEY: 0001007330 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ENGINEERING, ACCOUNTING, RESEARCH, MANAGEMENT [8700] IRS NUMBER: 582213805 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 GALLERIA PARKWAY STREET 2: STE 100 CITY: ATLANTA STATE: GA ZIP: 30339-5949 BUSINESS PHONE: 7707796610 MAIL ADDRESS: STREET 1: 600 GALLERIA PARKWAY STREET 2: STE 100 CITY: ATLANTA STATE: GA ZIP: 30339-5949 FORMER COMPANY: FORMER CONFORMED NAME: PRG-SCHULTZ INTERNATIONAL, INC. DATE OF NAME CHANGE: 20080327 FORMER COMPANY: FORMER CONFORMED NAME: PRG SCHULTZ INTERNATIONAL INC DATE OF NAME CHANGE: 20020125 FORMER COMPANY: FORMER CONFORMED NAME: PROFIT RECOVERY GROUP INTERNATIONAL INC DATE OF NAME CHANGE: 19960207 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-08 0 0001007330 PRGX GLOBAL, INC. PRGX 0001606872 Cochrane Michael 600 GALLERIA PARKWAY SUITE 100 ATLANTA GA 30339 0 1 0 0 SVP, Global Client Operations Common Stock 2018-03-08 4 M 0 35103 0.00 A 132782 D Common Stock 2018-03-08 4 F 0 11010 7.95 D 121772 D Performance-Based Restricted Stock Unit 0.00 2018-03-08 4 M 0 80000 0.00 D Common Stock 80000 0 D Includes 20,000 shares of restricted stock that vest in three equal installments on each of March 30, 2018, 2019 and 2020. Surrender of stock upon vesting of Performance-Based Restricted Stock Units ("Units") to satisfy tax withholding obligations. Each Unit corresponds to one share of common stock of the Company. Units that vested and became payable were payable 43% in common stock and 57% in cash. The Units were payable upon the determination by the Company's Compensation Committee on March 8, 2018 of the financial performance achieved by the Company for the two-year period ended December 31, 2017. /s/ Victor A. Allums, as Attorney-in-Fact for Michael Cochrane 2018-03-12